John Packs is listed as a director on 4 SEC Form D filings by 1 issuer between Jan 2023 and Jun 2025: Vitro Biopharma, Inc. (Golden, CO — biotechnology — 2023–2025; $3M reported sold to 10 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Caroline Mosessian (4 shared filings), James Musick (4 shared filings), Christopher Furman (3 shared filings), Nathan Haas (3 shared filings), Tiana States (3 shared filings) and 2 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around John. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 3 court cases matching the name, 4 bankruptcy cases matching the name listed in Key records below.
What this means 7 records came back, including 1 court case still open — open cases can take years and cost money. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 4 public filings for John Packs and found 6 differences: Form D filed 17 days after the first sale; Offering amount changed between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.